| 标题 |
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Gut 作者:Jing Liu; Xupeng Hou; Lin Li; Weiwei Bai; Tianxing Zhou; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |